More on GPCR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $22.88 |
|
|||
| Open | $23.00 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $23.32 | ||||
| Day Low | $21.77 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 607,110 | ||||
- Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026
- More than 175 biotechs adopt Veeva Basics for drug development ops
- Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
- Form 4 Structure Therapeutics For: Sep 18 Filed by: Coll Crespo Blas
- Form 144 Structure Therapeutics Filed by: Coll Crespo Blas
- H.C. Wainwright Reiterates Buy Rating on Structure Therapeutics (GPCR)
- Structure Therapeutics (GPCR) Reiterated at Market Outperform by Citizens
- Jefferies Reiterates Buy Rating on Structure Therapeutics (GPCR)
- Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management
- Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
Entities mentioned with GPCR
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- BMO Capital | View Related Stories »
- Jefferies & Co | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
